Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program

BACKGROUND: The Centers for Disease Control and Prevention contracted with laboratories to sequence the SARS-CoV-2 genome from positive samples across the United States to enable public health officials to investigate the impact of variants on disease severity as well as the effectiveness of vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, Chirayu, Sheldon, Michael, Bixby, Christian, Keddache, Mehdi, Bogdanowicz, Alexander, Wang, Yihe, Schultz, Jonathan, McDevitt, Jessica, LaPorta, James, Kwon, Elaine, Buyske, Steven, Garbolino, Dana, Biloholowski, Glenys, Pastuszak, Alex, Storella, Mary, Bhalla, Amit, Charlier-Rodriguez, Florence, Hager, Russ, Grimwood, Robin, Nahas, Shareef A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035976/
https://www.ncbi.nlm.nih.gov/pubmed/35468749
http://dx.doi.org/10.1186/s12879-022-07374-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035976/
https://www.ncbi.nlm.nih.gov/pubmed/35468749
http://dx.doi.org/10.1186/s12879-022-07374-7

Ejemplares similares